Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2000038976Phase 4Recruiting
Phase 4, randomised trial of remimazolam in postoperative delirium (POD) and Postcardiac surgery state (2 arms), sponsored by Liaocheng Cardiac Hospital. Primary endpoint: Incidence of delirium. Started Jul 2020; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2000038976.